Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer

Journal of Urology

Volumn 170, Issue 2 I, 2003, Pages 595-600

  Chang, Lin Li ^a   Yeh, Wen Ting ^a   Yang, Shu Yuan ^a   Wu, Wen Jeng ^a   Huang, Chun Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bladder; Carcinoma, transitional cell; Gene deletion; Gene expression; Methylation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; MESSENGER RNA; PROTEIN MDM2; PROTEIN P14; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CELL CYCLE; CHROMOSOME 9P; CONTROLLED STUDY; DNA METHYLATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE P14ARF; GENE P16INK4A; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0038507189     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000067626.37837.3e     Document Type: Article

References (20)

1. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. and Carson, D. A.: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368: 753, 1994
2. Chin, L., Pomeramtz, J. and DePinho, R. A.: The INK4a/ARF tumor suppressor: one gene - two products - two pathways. Trends Biochem Sci, 23: 291, 1998
3. Zhang, Y., Xoing, Y. and Yarbrough, W.: ARF promotes MDM2 degradation and stabilizes p53:ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92: 725, 1998
4. Gruis, N. A., Weaver-Feldhaus, F., Liu, Q., Frye, C., Eeles, R., Orlow, I. et al: Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am J Pathol, 146: 1199, 1995
5. Carins, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, Y. et al: Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science, 265: 415, 1994
6. Xing, E. P., Nie, Y, Song, Y., Yang, G. Y., Cai, Y. C., Wang, L. D. et al: Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res, 5: 2704, 1999
7. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E. et al: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res, 55: 4525, 1995
8. Esteller, M., Tortola, S., Toyota, M., Capella, G., Peinado, M. A., Baylin, S. B. et al: Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res, 60: 129, 2000
9. Iwato, M., Tachibana, O., Tohma, Y., Arakawa, Y., Nitta, H., Hasegawa, M. et al: Alterations of the INK4a/ARF locus in human intracranial germ cell tumors. Cancer Res, 60: 2113, 2000
10. Zochbauer-Muller, S., Fong, K. M., Virmain, A. K., Geradts, J., Gazder, A. F. and Minna, J. D.: Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res, 61: 249, 2001
11. Van Tilborg, A. A., Hekman, A. C., Vissers, K. J., van der Kwast, T. H. and Zwarthoff, E. C.: Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder. Int J Cancer, 75: 9, 1998
12. Wu, W. J., Kakehi, Y., Chang, S. F., Huang, C. H. and Chang, L. L.: Genetic alterations of the p16 gene in urothelial carcinoma in Taiwanese patients. BJU Int, 85: 143, 2000
13. Hermanek, P. and Sobin, L. H.: UICC (International Union Against Cancer). TNM Classification of Malignant Tumours. Berlin: Springer-Verlag, 1987
14. Mostofi, F. K., Sobin, L. H. and Torloni, H.: Histological Typing of Urinary Bladder Tumours. Geneva: World Health Organization, 1973
15. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D. and Baylin, S. B.: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 93: 9821, 1996
16. Spruck, C. H., 3rd, Gonzalez-Zulueta, M., Shibata, A., Simoneau, A. R., Lin, M. F., Gonzales, F. et al: p16 gene in uncultured tumours. Nature, 370: 183, 1994
17. Kamijo, T., Bodner, S., van de Kamp, E., Randle, D. H. and Sherr, C. J.: Tumor spectrum in ARF-deficient mice. Cancer Res, 59: 2217, 1999
18. Okajima, E., Fukuda, T., Okita, S., Tsutsumi, M., Hirao, Y., Okajima, E. et al: Infrequent somatic alteration of p16/MTS1 in human primary superficial bladder cancers. Cancer Lett, 103: 227, 1996
19. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S. and Nakamura, Y.: Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res, 54: 3396, 1994
20. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B. et al: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet, 8: 27, 1994